Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02296242
Brief Title: Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

First Submitted : November 13, 2014
First Submitted that Met QC Criteria : November 18, 2014
First Posted : November 20, 2014 (Estimate)

Results First Submitted : June 28, 2018
Results First Submitted that Met QC Criteria : August 6, 2018
Results First Posted : September 5, 2018

Last Update Submitted that Met QC Criteria : January 9, 2019
Last Update Posted : January 29, 2019